Sign in Sign up for free

Last updated: 23 July 2019 at 12:04am EST

Christopher J Margolin Net Worth




The estimated Net Worth of Christopher J Margolin is at least $1.57 Million dollars as of 31 March 2005. Christopher Margolin owns over 53,700 units of XOMA Royalty stock worth over $1,510,231 and over the last 21 years Christopher sold XOMA stock worth over $55,311.

Christopher Margolin XOMA stock SEC Form 4 insiders trading

Christopher has made over 2 trades of the XOMA Royalty stock since 2004, according to the Form 4 filled with the SEC. Most recently Christopher sold 53,700 units of XOMA stock worth $55,311 on 31 March 2005.

The largest trade Christopher's ever made was exercising 75,000 units of XOMA Royalty stock on 12 January 2004 worth over $187,500. On average, Christopher trades about 5,850 units every 20 days since 2003. As of 31 March 2005 Christopher still owns at least 55,687 units of XOMA Royalty stock.

You can see the complete history of Christopher Margolin stock trades at the bottom of the page.



What's Christopher Margolin's mailing address?

Christopher's mailing address filed with the SEC is C/O XOMA, LTD., 2910 SEVENTH STREET, BERKELEY, CA, 94710.

Insiders trading at XOMA Royalty

Over the last 22 years, insiders at XOMA Royalty have traded over $74,428,857 worth of XOMA Royalty stock and bought 6,217,869 units worth $44,091,555 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Partners L P/Ilbiotechnolog..., and Bros. Advisors Lp667, L.P.B.... On average, XOMA Royalty executives and independent directors trade stock every 31 days with the average trade being worth of $3,397,377. The most recent stock trade was executed by Owen Hughes on 2 October 2023, trading 1,000 units of XOMA stock currently worth $13,830.



What does XOMA Royalty do?

xoma has an extensive portfolio of products, programs, and technologies that are the subject of licenses the company has in place with other biotech and pharmaceutical companies. many of these licenses are the result of the company's pioneering efforts in the discovery and development of antibody therapeutics. there are more than 20 such programs that are fully funded by partners and could produce milestone payments and royalty payments in the future. in order to maximize its value in a licensing transaction, xoma continues to invest in x358, an allosteric monoclonal antibody that reduces insulin receptor activity, as the antibody could have a major impact on the treatment of hyperinsulinism. for more information, visit www.xoma.com.



What does XOMA Royalty's logo look like?

XOMA Royalty Corp. logo

Complete history of Christopher Margolin stock trades at XOMA Royalty

Date
#
Company
 Insider
Trans.
Transaction
 Shares Price per share Total value Shares after Source
31 Mar 2005 XOMA XOMA Royalty Corp. Christopher J Margolin
Vice President, General Counsel, and Sec'y
 Sale 53,700 $1.03 $55,311
31 Mar 2005
55,687 ↗
12 Jan 2004 XOMA XOMA Royalty Corp. Christopher J Margolin
Vice President, General Counsel, and Sec'y
 Option 75,000 $2.50 $187,500
12 Jan 2004
80,503 ↗


XOMA Royalty executives and stock owners

XOMA Royalty executives and other stock owners filed with the SEC include: